Walleye Capital LLC bought a new position in shares of Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 19,928 shares of the medical equipment provider’s stock, valued at approximately $988,000.
Several other hedge funds have also added to or reduced their stakes in the business. Nantahala Capital Management LLC boosted its position in Semler Scientific by 27.9% during the 1st quarter. Nantahala Capital Management LLC now owns 356,875 shares of the medical equipment provider’s stock worth $17,687,000 after buying an additional 77,790 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Semler Scientific by 49.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 227,529 shares of the medical equipment provider’s stock worth $11,276,000 after purchasing an additional 75,574 shares during the period. EVR Research LP acquired a new position in shares of Semler Scientific in the 1st quarter worth approximately $9,912,000. Avalon Investment & Advisory lifted its position in shares of Semler Scientific by 244.0% in the 1st quarter. Avalon Investment & Advisory now owns 157,534 shares of the medical equipment provider’s stock worth $7,807,000 after purchasing an additional 111,743 shares during the period. Finally, Wasatch Advisors Inc. acquired a new position in shares of Semler Scientific in the 4th quarter worth approximately $10,898,000. 37.99% of the stock is currently owned by institutional investors and hedge funds.
Semler Scientific Stock Performance
Shares of OTCMKTS SMLR opened at $39.69 on Tuesday. The company has a market capitalization of $269.93 million, a P/E ratio of 24.65 and a beta of 0.72. Semler Scientific, Inc. has a 52-week low of $27.02 and a 52-week high of $153.21. The company’s 50 day moving average price is $38.93 and its 200-day moving average price is $38.35.
Semler Scientific Profile
Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
- Get a free copy of the StockNews.com research report on Semler Scientific (SMLR)
- Oracle’s Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin’ It: Investors Keep Visiting McDonald’s
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.